drugset / Trial / NCT05464836
Phase II Study to Evaluate Safety and Efficacy of CB-103 With Venetoclax in Adolescent and Young Adult Patients With Relapsed/Refractory T-ALL or T-LBL
NaSingle-groupOpen-labelTreatment
Summary
To learn if the combination of 2 study drugs, CB-103 and venetoclax, can help to control T-cell acute lymphoblastic leukemia (T-ALL) or T-cell lymphoblastic leukemia (T-LBL) in adolescent and young adult patients
Timeline
- Start
- 2023-04-06
- Primary completion
- 2024-08-12
- Completion
- 2024-08-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | LIMANTRAFIN | Small molecule | — | Oral |
| Subject | Venetoclax | Small molecule | — | Oral |